Organization
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, United States
4 abstracts
Abstract
A PHASE 2 TRIAL OF PERESOLIMAB FOR ADULTS WITH RHEUMATOID ARTHRITISOrg: Eli Lilly and Company, San Diego Clinical Services, San Diego State University Department of Biology, San Diego, CA, United States of America, Csolnoky Ferenc Hospital,
Abstract
AN EVAULATION OF THE SAFETY AND EFFICACY OF DULOXETINE IN THE TREATMENT OF WOMEN WITH FIBROMYLGIA SYNDROME: RESULTS FROM TWO CLINICAL STUDIESOrg: Abbott Laboratories, Abbott Park, Abbott Park, IL, United States, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, United States, Eli Lilly and Company,
Abstract
ACTIVE COMPARATOR TRIAL OF TERIPARATIDE VERSUS ALENDRONATE IN THE TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSISOrg: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, United States,
Abstract
BARICITINIB DECREASES ANTI-DSDNA AND IGG ANTIBODIES IN ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS FROM A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIALOrg: Eli Lilly and Company, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, United States, Cedars-Sinai Medical Center, University California at Los Angeles,